Omaron 90 pills

Omaron (Piracetamum + Cinnarizinum, Piracetam + Cinnarizine) - combined medication with anti-hypoxic, neuroprotective and vasodilator effect.

Piracetam activates the metabolic processes in the brain by enhancing the energy and protein metabolism, accelerate the utilization of glucose into cells and increase their resistance to hypoxia, improves interneuronal transmission in the central nervous system, improves regional blood flow in the ischemic area.

Cinnarizine - selective blocker of slow calcium channels inhibits calcium ion entry into cells and reduces their content in the depot plasmolemma reduces the tonus of smooth muscle of the arterioles, reduces their response to biogenic vasoconstrictors (epinephrine, norepinephrine, dopamine, angiotensin, vasopressin). It has a vasodilating effect (particularly with regard to vessels of the brain, strengthening anti-hypoxic effect of piracetam), without significant effects on blood pressure. Exhibits mild antihistamine activity, reduces the excitability of the vestibular apparatus, lowers the tone of the sympathetic nervous system. Erythrocyte membrane elasticity increases, their ability to deform, reducing blood viscosity.

Testimony:

• Cerebrovascular insufficiency (including atherosclerosis, cerebral blood vessels, reducing post-ischemic and hemorrhagic stroke, traumatic brain injury);
• Encephalopathy different genesis;
• Intoxication;
• Other CNS diseases associated with decreased intellectual-mental functions (such as impaired memory, attention and mood);
• Psycho-organic syndrome with prevalence of signs of fatigue and adinamii;
• Asthenic syndrome;
• Labirintopatii;
• Meniere's syndrome;
• Backlog of intellectual development in children;
• Prevention of migraine and kinetoses.

Contraindications:

• Severe hepatic dysfunction;
• Severe renal impairment;
• Pregnancy;
• Lactation;
• Children under 5 years old;
• Hypersensitivity to the drug.

Special instructions:

Precautions should be prescribed to patients with liver disease and / or kidney. In renal insufficiency, mild to moderate severity, especially in QC

In patients with impaired hepatic function should be monitored content of liver enzymes.

Precautions should be prescribed to patients with increased intraocular pressure, as well as in Parkinson's disease.

During treatment should avoid alcohol.

Effects on ability to drive vehicles and management mechanisms

During treatment, patients should be careful when driving and operating machinery.

Drug interactions:

In an application with Omaron may increase the sedative action of oppressive central nervous system activity and neuroprotective, antihypertensive drugs, ethanol.

Vasodilators increase the effect of the drug.

Omaron improves the tolerability of antipsychotic drugs and tricyclic antidepressants.

Suggested Use:

Adults appoint Table 1-2. 3 times / day for 1-3 months depending on the severity of the disease; Children - 1-2 tab. 1-2 times / day. Do not use the drug for more than 3 months.

Packaging:

• Comes in original packaging. Item is brand new and unopened.

Storage:

• Keep away from direct sunlight.
• Keep locked and away from children.
• Store in dry place at room temperature.
• Do not exceed storage temperature higher than 25 C

Important notice- the outer box design may vary before prior notice!